1

CURRICULUM VITAE

JOY MELNIKOW, M.D., M.P.H.

Professor Department of Family and Community Medicine

School of Medicine University of California, Davis

Office Address: University of California, Davis

Dept. of Family & Community Medicine

Lawrence J. Ellison Ambulatory Care Center 4860 Y. Street, Suite 2320 TEL: (916) 734 - 3160 Sacramento, CA 95817 FAX: (916) 734 - 5641

E-mail: jamelnikow@ucdavis.edu

EMPLOYMENT July 2002 – Present Professor, Department of Family and Community Medicine August 2009-Present Director, UC Davis Center for Healthcare Policy and Research July 2007—July 2009 Associate Director, UC Davis Center for Healthcare Policy and

Research 1998 – 2002 Associate Professor 1992 – 1998 Assistant Professor Responsibilities include teaching and supervision of residents and medical students with a particular focus on problem-based learning, evidence-based medicine and maternal child health; mentoring and supervision of research fellows; mentoring junior faculty, providing direct outpatient and inpatient care; obtaining grant funding for, and conducting research projects, and assisting the Director of CHPR. Current research interests include women’s health, patient preferences and decision-making, preventive services, cancer prevention and early detection, underserved populations and cost-effectiveness analysis. Past Positions: Faculty Physician/Research Director Department of Family Practice

2

MetroHealth Medical Center Cleveland, OH 8/88 - 8/92 Assistant Professor Department of Family Medicine Case Western Reserve University, School of Medicine Cleveland, OH 8/88 - 8/92 Family Physician Fort Defiance Indian Hospital Fort Defiance, AZ 7/87 - 7/88 LICENSURE/CERTIFICATION California License #G074912 Diplomate, American Board of Family Practice, 9/87 Recertified 9/93, 9/99, 9/2005. Memberships: American Academy of Family Physicians, California Academy of Family Physicians, Society of Teachers of Family Medicine, American Public Health Association, North American Primary Care Research Group, Society for Medical Decision Making. EDUCATION University of California, San Francisco School of Medicine San Francisco, CA M.D. Alpha Omega Alpha 6/84 University of California, Berkeley School of Public Health Berkeley, CA M.P.H. Epidemiology 6/83 San Francisco State University San Francisco, CA B.A. Summa cum laude, Phi Beta Kappa Liberal Studies 6/79

3

Post Graduate Training: University of Massachusetts Department of Family and Community Medicine Residency, Family Practice 7/84 - 6/87 HONORS AND AWARDS 2013 Academic Senate Distinguished Scholarly Public Service Award 1996 Christine Landgraff Award for cancer research 1993 Promoting successful breastfeeding skills for family physicians (with J. Bedinghaus) Walter Kemp Award for the best paper published in the Am Fam Physician authored by

family physicians 1984 Alpha Omega Alpha 1979 Summa Cum Laude, Phi Beta Kappa SERVICE: Let’s Get Healthy California Task Force Member 2012 Vice Chair for Public Health, California Health Benefits Review Program 2010-present US Preventive Services Task Force Member 2009-present California Health Benefits Review Program Task Force Member 2007-2009 Deputy Editor -- Medical Care 2007-present National Institutes of Health – Health Services Organization and Delivery study section standing member 2007-present Associate Medical Director, Healthwise, Inc. - review and edit consumer health information

related to women’s health 1998-2009 Wellstart, Inc. Lactation Management curriculum reviewer 1993 Agency for Health Care Policy and Research - Small Grant reviewer NCI Special Emphasis Panel Minority-based Community Clinical Oncology Program ad hoc

reviewer California Medical Board, (Sacramento Region), Case Reviewer, Examiner Board of Directors, American Cancer Society, Sacramento Region, September 1999-2003 California Osteoporosis Prevention and Education Advisory Panel 2000-2002 Agency for Health Care Policy and Research Small Grant Review Group. August, 1997

4

PUBLICATIONS Peer-reviewed Journals: Nishijima DK, Haukoos JS, Newgard CD, Staudenmayer K, White N, Slattery D, Maxim PC, Gee CA, Hsia RY, Melnikow JA, Holmes JF. Variability of ICU Use in Adult Patients With Minor Traumatic Intracranial Hemorrhage. Ann Emerg Med. 2012 Sep 26. pii: S0196-0644(12)01423-0. doi: 10.1016/j.annemergmed.2012.08.024. [Epub ahead of print] PubMed PMID: 23021347. Moyer VA; U.S. Preventive Services Task Force. Screening for Ovarian Cancer: U.S. Preventive Services Task Force Reaffirmation Recommendation Statement. Ann Intern Med. 2012 Sep 11. doi: 10.7326/0003-4819-157-11-201212040-00539. [Epub ahead of print] PubMed PMID: 22964825. Moyer VA; U.S. Preventive Services Task Force. Screening for Chronic Kidney Disease: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med. 2012 Aug 28. doi: 10.7326/0003-4819-157-8-201210160-00533. [Epub ahead of print] PubMed PMID: 22928170. Moyer VA; U.S. Preventive Services Task Force. Screening for Hearing Loss in Older Adults: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med. 2012 Aug 14. doi: 10.7326/0003-4819-157-9-201211060-00526. [Epub ahead of print] PubMed PMID: 22893115. Moyer VA; U.S. Preventive Services Task Force. Prevention of falls in community-dwelling older adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2012 Aug 7;157(3):197-204. PubMed PMID: 22868837. Moyer VA; U.S. Preventive Services Task Force*. Screening for Coronary Heart Disease With Electrocardiography: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med. 2012 Jul 31. doi: 10.7326/0003-4819-157-7-201210020-00514. [Epub ahead of print] PubMed PMID:22847227. Moyer VA; U.S. Preventive Services Task Force. Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med.2012 Jul 17;157(2):120-34. PubMed PMID: 22801674. Melnyk BM, Grossman DC, Chou R, Mabry-Hernandez I, Nicholson W, DeWitt TG,Cantu AG, Flores G; US Preventive Services Task Force. USPSTF perspective onevidence-based preventive recommendations for children. Pediatrics. 2012Aug;130(2):e399-407. Epub 2012 Jul 2. PubMed PMID: 22753558. Moyer VA; U.S. Preventive Services Task Force. Behavioral counseling to prevent skin cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2012 Jul 3;157(1):59-65. Review. PubMed PMID:22751761. Moyer VA; U.S. Preventive Services Task Force. Behavioral Counseling Interventions to Promote a Healthful Diet and Physical Activity for Cardiovascular Disease Prevention in Adults: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med. 2012 Jun 26.

5

doi: 10.7326/0003-4819-157-5-201209040-00486. [Epub ahead of print] PubMed PMID:22733153. Moyer VA; U.S. Preventive Services Task Force. Screening for and Management of Obesity in Adults: U.S. Preventive Services Task ForceRecommendation Statement. Ann Intern Med. 2012 Jun 26. doi: 10.7326/0003-4819-157-5-201209040-00475. [Epub ahead of print] PubMed PMID: 22733087. Stoltzfus JC, Nishijima D, Melnikow J. Why quantile regression makes good sense for analyzing economic outcomes in medical research. Acad Emerg Med. 2012 Jul;19(7):850-1. doi: 10.1111/j.1553-2712.2012.01386.x. Epub 2012 Jun 22. PubMed PMID: 22724505. Moyer VA; U.S. Preventive Services Task Force. Screening for cervical cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2012 Jun 19;156(12):880-91, W312. PubMed PMID: 22711081. Moyer VA; U.S. Preventive Services Task Force. Screening for bladder cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2011 Aug 16;155(4):246-51. Erratum in: Ann Intern Med. 2011 Sep 20;155(6):408. PubMed PMID: 21844550. U.S. Preventive Services Task Force. Screening for testicular cancer: U.S. Preventive Services Task Force reaffirmation recommendation statement. Ann Intern Med. 2011 Apr 5;154(7):483-6. PMID: 21464350 U.S. Preventive Services Task Force. Screening for osteoporosis: U.S. preventive services task force recommendation statement. Ann Intern Med. 2011 Mar 1;154(5):356-64. Epub 2011 Jan 17. PMID: 21242341 US Preventive Services Task Force. Vision screening for children 1 to 5 years of age: US Preventive Services Task Force Recommendation statement. Pediatrics. 2011 Feb;127(2):340-6. Epub 2011 Jan 31. PMID: 21282267 Baker D, Melnikow J, Ly M, Shoultz J, Niederhauser V, Escamilla R. Translation of Health Surveys using Mixed Methods. J Nurs Scholarsh. 2010;42:430-8. Epub 2010 Oct 7. PMID: 21091626. Melnikow J, Kulasingam S, Slee C, Helms LJ, Kuppermann M, Birch S, McGahan CE, Coldman A, Chan BK, Sawaya GF. Surveillance after treatment for cervical intraepithelial neoplasia: outcomes, costs, and cost-effectiveness. Obstet Gynecol. 2010;116:1158-70. PMID: 20966702. Kuppermann M, Melnikow J, Slee C, Tancredi DJ, Kulasingam S, Birch S, Helms LJ, Bayoumi AM, Sawaya GF. Preferences for surveillance strategies for women treated for high-grade precancerous cervical lesions. Gynecol Oncol. 2010 Aug 1;118(2):108-15.

6

Melnikow J, McGahan C, Sawaya G, Ehlen T, Coldman A. Cervical intraepithelial neoplasia outcomes after treatment: Long-term follow-up from the British Columbia Cohort Study. J Natl Cancer Inst. 2009;101:721-8. Chan B, Melnikow J, Slee C, Arellanes R, Sawaya G. Posttreatment human papillomavirus testing for recurrent cervical intraepithelial neoplasia: a systematic review. Am J Obstet Gynecol. 2009;200(4):422 e1-9. Melnikow J, Birch S, Slee C, McCarthy T, Helms J, Kuppermann M. Tamoxifen for Breast Cancer Risk Reduction: Impact of Alternative Approaches to Quality-of-Life Adjustment on Cost-Effectiveness Analysis. Med Care. 2008; 46: 946-53. Franks P, Lubetkin EI, Melnikow J. Do personal and societal preferences differ by socio-demographic group? Health Econ. 2007;16:319-25. Melnikow J, Kuenneth C, Helms LJ, Barnato A, Kuppermann M, Birch S, Nuovo J. Chemoprevention: Drug Pricing and Mortality -- The Case of Tamoxifen. Cancer 2006; 107:950-58. Kulasingam SL, Myers ER, Lawson HW, McConnell KJ, Kerlikowske K, Melnikow J, Washington AE, Sawaya GF. Cost-effectiveness of Extending Cervical Cancer Screening Intervals Among Women With Prior Normal Pap Tests. Obstetrics & Gynecology 2006; 107:2:321-328. Keyser JF, Melnikow J, Kupperman M, Birch S, Kuenneth C, Nuovo J, Azari R, Oto-Kent D, Rooney M. Recruitment Strategies for Minority Participation: Challenges and Cost Lessons from the POWER Interview. Ethnicity & Disease 2005; 15:395-406. Paterniti DA, Melnikow J, Nuovo J, Henderson S, DeGregorio M, Kuppermann M, Nease R. “I’m Going To Die of Something Anyway”: Women’s Perceptions of Tamoxifen for Breast Cancer Risk Reduction. Ethnicity & Disease 2005; 15:365-372. Melnikow J, Paterniti D, Azari R, Kuenneth C, Birch S, Kuppermann M, Nuovo J, Keyzer J, Henderson S. Preferences of Women Evaluating Risks of Tamoxifen (POWER) study of preferences for tamoxifen for breast cancer risk reduction. Cancer 2005;103:1996-2005. Kravitz RL, Melnikow J. Medical adherence research: time for a change in direction? Med Care. 2004;42:197-9. Sawaya GF, McConnell J, Kulasingam SL, Lawson HW, Kerlikowske K, Melnikow J, Lee NC, Gildengorin G, Myers ER, Washington AE. Risk of Cervical Dysplasia and Cancer Associated with Extending the Interval between Cervical-Cancer Screenings. N Engl J Med 2003;349:1501-1509. Kravitz RL, Melnikow J, Romano PS, Franz CE, Gilbert W, Zach A, Paterniti DA, Krackardt D. Networked for change? Identifying obstetric opinion leaders and assessing their opinions on cesarean delivery. Social Science and Medicine, 2003;57:2423-2434. Birch S, Melnikow J, Kuppermann M. Conservative versus aggressive follow up of mildly abnormal Pap smears: Testing for process utility. Health Economics 2003;7:3-8.

7

Melnikow J, Kuppermann M, Birch S, Chan BK, Nuovo J. Management of the low-grade abnormal Pap smear: What are women’s preferences? J Fam Pract 2002;51:849-855. Nuovo J, Melnikow J, Chang D. Reporting number needed to treat and absolute risk reduction in randomized controlled trials. JAMA 2002;282:2813-14. Nuovo J, Melnikow J, Howell L. New tests for cervical cancer screening. American Family Physician 2001;64:780-6. Melnikow J, Romano PS, Gilbert WM, Schembri M, Keyzer J, Kravitz RL. Vaginal birth after cesarean—In California. Obstetrics and Gynecology 2001; 98:421-6. Melnikow J, Kohatsu ND, Chan BKS. Put prevention into practice: A controlled evaluation. Am J Pub Health 2000;90:1622-1625. Kravitz RL, Helms LJ, Azari R, Antonius D, Melnikow J. Comparing the use of physician time and health care resources among patients speaking English, Spanish and Russian. Med Care 2000;38:728-738. Nuovo J, Melnikow J, Willan AR, Chan BKS. Treatment outcomes for squamous intraepithelial lesions. International Journal of Gynecology & Obstetrics 2000;68:25-33. Melnikow J, Chan BK, Stewart GK. Do follow-up recommendations for abnormal Papanicolaou smears influence patient adherence? Arch Fam Med 1999; 8:510-514. Helms LJ, Melnikow J. Determining costs of health care services for cost-effectiveness analyses: the case of cervical cancer prevention and treatment. Med Care, 1999;37:652-661. Melnikow J, Nuovo J, Willan AR, Chan BK, Howell LP. Natural history of cervical squamous intra-epithelial lesions: a meta-analysis. Obstet Gynecol 1998;92:727-735. Nuovo J, Melnikow J, Hutchison B, Paliescheskey M. Is cervicography a useful diagnostic test? A systematic review of the literature. J Am Board Fam Prac 1997;10:390-397. Melnikow J, Nuovo J, Paliescheskey M, Stewart GK, Howell L, Green B. Detection of High Grade Cervical Dysplasia: Impact of Age and Bethesda System-related Follow-up Criteria. Diagnostic Cytopathol 1997;17:321-325. Melnikow J, Paliescheskey M, Stewart GK. Effect of a transportation incentive on compliance with the first prenatal appointment: A randomized trial. Obstet Gynecol 1997;89:1023-1027. Melnikow J, Nuovo J. Cancer prevention and screening in women. Primary Care Clinics of North America 1997;24:15-26. Melnikow J, Nuovo J, Paliescheskey M. Management choices for patients with "squamous atypia" on papanicolaou smear: A toss up? Medical Care 1996;34:336-347. Nuovo J, Melnikow J, Paliescheskey, M. Management of patients with atypical and low-grade pap smear abnormalities. Am Fam Physician 1995;52:2243-2250.

8

Nuovo J, Melnikow J, Paliescheskey M., King J, Mowers, R. Cost-effectiveness analysis of five different antibiotic regimens for the treatment of uncomplicated chlamydia trachomatis cervicitis. J Am Board Fam Pract 1995;8:7-16. Melnikow J, Bedinghaus J. Management of common breastfeeding problems. J Fam Pract 1994;39:56-64. Melnikow J, Kiefe CL. Patient compliance and medical research: Issues in methodology. J Gen Int Med 1994;9:96-105. Headrick, L, Neuhauser, D, Melnikow, J. VE. Asthma Health Status. Ongoing Measurement in the Context of Continuous Quality Improvement. Medical Care 1993;31:97-106. Melnikow J, Alemagno S. Adequacy of prenatal care among inner city women: A case control study. J Fam Prac 1993;37:575-582. Melnikow J, Sierk A, Flocke S, Peters C. Does the system of pap smear nomenclature influence the rate of referral for colposcopy? A survey of family physicians, Arch Fam Med 1993;2:253-258. Headrick L, Neuhauser D, Melnikow J, Vanek E. Teaching medical students about quality and cost of care: The CWRU Asthma Project. Acad Med 1992;67:157-159. Stange KC, Kelly R, Chao J, Zyzanski SJ, Shank JC, Jaen CR, Melnikow J, Flocke S. Physician agreement with the recommendations of the U.S. Preventive Services Task Force. J Fam Pract 1992;34:409-416. Bedinghaus J, Melnikow J. Promoting successful breastfeeding: skills for family physicians. Am Fam Physician 1992;45:1309-1318. Headrick L, Neuhauser D, Melnikow J, Vanek E. Introducing quality improvement thinking to medical students: The Cleveland Asthma Project. QRB 1991;17:254-260. Melnikow J, Alemagno S, Rottman C, Zyzanski S. Characteristics of inner-city women giving birth with little or no prenatal care: a case-control study. J Fam Pract 1991;32:283-288. Bernstein RL, Melnikow J. Possible carcinogenic risk in the biochemical laboratory. Biochem Ed 1982;8:04-06. Melnikow J, Bernstein RL, Keefe J. Carcinogens and mutagens in the undergraduate laboratory. J Chem Ed 1981;58:11-14. Abstracts: New Technology for Breast Cancer Screening: Pragmatic Cost Effectiveness Analysis for a State Safety-net Program. North American Primary Care Research Group 38th Annual Meeting. Seattle, WA, November 2010

9

Strategies for Surveillance After Treatment for Cervical Intraepithelial Neoplasia (CIN): Costs and Outcomes. North American Primary Care Research Group 37th Annual Meeting. Montreal, Quebec, November 2009. Surveillance After Treatment for CIN: HPV Testing is Not Cost-Effective. Papillomavirus Conference. 25th International meeting, Malmo, Sweden. May 2009 The HPV Vaccine: Information Needs, Barriers, and Disparities. North American Primary Care Research Group. 36th Annual Meeting, San Juan, Puerto Rico. November 2008. Recurrent of Cervical Intraepithelial Neoplasia Following Treatment: A Population-bases Cohort Study. North American Primary Care Research Group. 35th Annual Meeting,. October 2007. Tamoxifen Decision Making: Which Utilities to Choose? Poster presented at 28th Annual Meeting Society for Medical Decision Making. Boston, Massachusetts, October 15-18, 2006. Race in the Gail Model of Breast Cancer. Generalist Physicians as Agents for Change: Education and Research Practice and Policy. SGIM 26th Annual Meeting. Vancouver, British Columbia, April 30-May 3, 2003. Breast Cancer Concern and Sources of Breast Cancer Information. Generalist Physicians as Agents for Change: Education and Research Practice and Policy. SGIM 26th Annual Meeting. Vancouver, British Columbia, April 30-May 3, 2003. Tamoxifen Prevention of Breast Cancer: Is it Acceptable to Women at Risk? Generalist Physicians as Agents for Change: Education and Research Practice and Policy. SGIM 26th Annual Meeting. Vancouver, British Columbia, April 30-May 3, 2003. Melnikow J, Berger C, Paterniti D, Nuovo J, Kuenneth C. Breast Cancer Concern and Sources of Breast Cancer Information. Journal of General Internal Medicine 2003; 18(supp):303. Crichlow R, Melnikow J, Nuovo J. Race in the Gail Model of Breast Cancer. Journal of General Internal Medicine 2003; 18(supp):171. Melnikow J, Paterniti D, Henderson S, Nuovo J, Degregorio M, Kuppermann M, Nease R. Tamoxifen for Breast Cancer Risk Reduction: Women’s Perspectives. Journal of General Internal Medicine 2001;16(supp):230. Melnikow J. Put prevention into practice. Is it effective? A controlled evaluation. 2000 Annual Spring Conference Research Abstracts, Family Medicine 2000;32:470. Invited Editorials/Commentaries: LeFevre ML, Calonge N, Dietrich AJ, Melnikow J. Mammography screening for breast cancer: recommendation of the U.S. Preventive Services Task Force. Am Fam Physician 2010;82:602,609. PMID: 20842987. Melnikow J. ACP Journal Club. Review: Tamoxifen, raloxifene, and tibolone prevent primary invasive breast cancer but increase risk for adverse outcomes. Ann Intern Med 2010;152:JC3-4. PMID: 20231558.

10

Melnikow J, Review: vaccines against human papillomavirus prevent cervical cancer precursors in young women for at least 3 years. Evid Based Med, 2007. 12:168. Melnikow J, Birch S. Human papillomavirus triage of atypical squamous cells of undetermined significance: cost-effective, but at what cost? J Natl Cancer Inst. 2006; 98:82-3. Kravitz RL, Melnikow J. Medical adherence research. Time for a change in direction? Medical Care. 2004;42:197-199. Melnikow J. Water soluble get lubricant on vaginal speculums had no effect on cervical cytology results. Evidence Based Medicine, 2003;8:78-79. Kravitz R, Melnikow J. Engaging patients in medical decision making. British Medical Journal, 2001;323:584-5. Melnikow J, Nuovo J. A higher level of human papillomavirus 16 DNA was associated with an increased risk for cervical carcinoma in situ. ACP Journal Club, 2001;134:34-35. Melnikow J, Nuovo J. A higher level of human papillomavirus 16 DNA was associated with an increased risk for cervical carcinoma in situ. Evidence Based Medicine, 2001;6:29-30. Melnikow J, Nuovo J. Newer technologies improve sensitivity in detecting uterine cervical lesions, but at a substantially increased cost. Commentary. APC Journal Club, 2000;133:34. Nuovo J, Melnikow J. The extended tip spatula is more effective than the Ayre’s spatula for detecting karyosis in cervical smears. Commentary. Evidence Based Medicine, 2000;5:122-123. Nuovo J, Melnikow J. The extended tip spatula is more effective than the Ayre’s spatula for detecting karyosis in cervical smears. Commentary. ACP Journal Club, 2000, 133:30. Melnikow J, Nuovo J. Newer technologies improve sensitivity in detecting uterine cervical lesions but at a substantially increased cost. Commentary. ACP Journal Club, 2000, 133:34. Melnikow J. Oral contraceptive use associated with myocardial infarction and ischemic stroke but not angina. Commentary. WJM 1999;171:89. Melnikow J. Oral contraceptive use associated with myocardial infarction and ischemic stroke but not angina. Commentary. Evidence Based Medicine, 1999;4:93. Melnikow J, Nuovo J. Reducing mortality due to cervical cancer: Papnet fails the test. (editorial). Arch Fam Med 1999;8:56-57. Melnikow J. Incremental cost-effectiveness of double vs single reading of mammograms. Commentary. Evidence Based Medicine 1996;1:224. Nuovo, J, Melnikow: Reply Letter to the Editor. Am Fam Physician 1996;54:462-5. Melnikow J. Nonfatal venous thromboembolism was associated with oral contraceptives containing desogestrel and gestodene. Commentary. ACP Journal Club 1996;124:79.

11

Nuovo J, Melnikow J. Colposcopy training in residency programs: A new dilemma. Fam Med 1996;28:502-4. Melnikow J. Calcium supplementation during pregnancy. J Fam Prac Journal Club 1996;43:115-116. Melnikow J. Hormone replacement therapy and breast cancer risk. J Fam Pract Journal Club 1995;41:501-502. Melnikow J. Electrosurgical loop excision of the transformation zone. J Fam Pract Journal Club 1995;41:337-44. Nuovo J, Melnikow J, Paliescheskey M. When the pap smear shows inflammation. Patient Care 1995;29:151-53. Melnikow J. Computerized reminders increased use of mammography. Commentary. ACP Journal Club 1995;122:25. Melnikow J. Radiologists differed in their interpretations of mammograms. Commentary. ACP Journal Club 1995;74. Limited Distribution: Melnikow J, Correa D, Finta L, King J, Mowers R, Oi R, Robbins J, Sauer B, Shelton D. Osteoporosis – Guidelines for Screening and Prevention. Drug Perspectives, August 1999. Wagman LD, Ganz P, Howell L, Melnikow J, Talavena G, Beatty C. Breast Diagnostic Algorithms for Primary Care Clinicians. Cancer Detection Section. California Department of Health Services. July, 1996. Melnikow J, Nesbitt T, Fox-Garcia, J. Establishing a Certified Nurse Midwife Practice in Northern California. Protocol Guide. California Department of Health Services, Department of Maternal and Child Health. February, 1995. Headrick L, Neuhauser D, Melnikow J, Vanek E, and Primary Care Clerkship Students CWRU School of Medicine. Quality and cost of care: Workbook of the CWRU Cleveland Asthma Project. Cleveland, Case Western Reserve University, 1992. Book Chapters: Melnikow J, Nuovo J. Cancer Prevention and Screening in Women. Primary Care Clinics: Women’s Health. W.B. Saunders Company 1997;24:15-26. Melnikow J. Lactation. Women’s Health. Williams and Wilkins 1996;661-675. GRANTS Centers for Disease Control Evidence-based Tools for Promoting Health Policy and Disease Prevention

12

Design of evidence-based cost effectiveness model to evaluate selected health prevention policy options. Co-PI: Melnikow 9/1/11-8/31/12. $150,000 California Breast Cancer Research Program This project is aimed at creating a user-friendly computer interface that will help to integrate research evidence on breast cancer screening into health policy. PI: Melnikow 7/01/2011-12/31/2012. $149,996 NCRR/ NIH ARRA - “Comparative Effectiveness Research Methods: Developing a Sustainable Course for Clinical Research Trainees” Oversee development of the CER curriculum insuring that it is successfully delivered to the trainees. Berglund (PI) Melnikow: Project Director 9/1/10-8/31/11. $305,789 Agency for Healthcare Quality and Research. RCT of US vs CT for Patients in the ED with Suspected Renal Colic. An RCT evaluating the use of renal ultrasound compared to CT for diagnosis of renal colic. Dr. Melnikow will direct the economic analysis. Smith-Bindman, UCSF,(PI), Mills, UC Davis, (Co-PI), Melnikow, (co-Investigator ). UC Davis subcontract $598, 835. 8/1/10-7/31/13. California Health Benefits Review Program. Oversee the conduct of analyses of the public health impact in California of proposed legislation mandating health benefits or rescinding previous mandated benefits. 9/2010-8/2011. $192,000 (Principal Investigator) California Program on Access to Care. New Technology for Breast Cancer Screening: Impact on the State Safety-net Program for the Underserved. 4/09-4/10. $65,000 (Principal Investigator) UC Davis Translational Breast Cancer Research Pilot Grant. Adjuvant Hormonal Therapy: Decision making and Adherence. 12/08-11/09. $30,000 (Principal Investigator) National Institutes of Health/Clinical Translational Science Center Pilot Grant. HPV vaccine: Educational Tools to Reduce Disparities. 5/07-4/08. $25,000 (Principal Investigator) National Institutes of Health/National Cancer Institute. Surveillance Strategies Following Treatment for CIN. 6/05–5/10. $656,328. (Principal Investigator) Catholic Health Care West. Cancer Priorities in the Latino Community. 1/06–12/06. $25,000. (Principal Investigator) Centers for Disease Control. Cervical Cancer Rescreening: Clinical and Economic Outcomes. 7/01–1/03. $338,575. (Sub-contract Principal Investigator) National Cancer Institute. Tamoxifen – Breast Cancer: Acceptance/Cost Effectiveness. (Principal Investigator) Minority Supplement for Renee Crichlow. 4/01–3/03. $110,880. National Cancer Institute. Tamoxifen Prevention of Breast Cancer: Acceptance and cost effectiveness. 4/00–3/03. $557,591. (Principal Investigator) California Breast Cancer Research Program. Tamoxifen Prevention of Breast Cancer: Is it Acceptable to Women at Risk? 7/99-6/01. $321,000. (Principal Investigator)

13

Centers for Disease Control and Prevention/Planned Parenthood, Mar Monte. Evaluation of Intimate Partner Violence Prevention Program. 12/97 - 9/00. $85,000. (Principal Investigator) California Office of Statewide Health Planning and Development. Process of Care in high c-section vs. low c-section hospitals. 7/97 - 1/99. $155,000. (Co-investigator) Susan G. Komen Foundation. Regional Orchestration of Office System Intervention. 10/95- -10/96. $38,313. (Principal Investigator) American Cancer Society Cancer Control Career Development Award for Primary Care Physicians -- 7/95 - 6/98. $90,000. (Principal Investigator) National Cancer Institute. Abnormal Pap Smears: What is Cost Effective Management? -- 7/95 - 6/97. $390,000. (Principal Investigator) Wellness Foundation. Put Prevention into Practice: A Controlled Evaluation of a New Preventive Services Initiative. 6/94. $111,000. (Principal Investigator with N. Kohatsu) American Academy of Family Physicians Foundation. Improving Prenatal Care Compliance: A Randomized Trial. 8/93. $14,004. (Principal Investigator) New Faculty Research Grant, University of California, Davis. Management of patients with "atypia" on pap smear: A decision analysis. 1/93. $2,500. American Academy of Family Physicians Foundation: Does the system of pap smear nomenclature affect the rate of referral for colposcopy? A survey of family physicians (with A. Sierk). 7/91. $1,185. MetroHealth Foundation: Factors Affecting Follow-up of Abnormal Pap Smears in a Multiracial Group of Inner City Women (with A. Sierk, S. Zyzanski). 2/91. $4,000. Ohio Academy of Family Physicians: Lack of Prenatal Care Among Inner City Women. 9/90. $4,200. Department of Family Medicine, CWRU: Does Prenatal Family Functioning Predict Postnatal Compliance with Well Child Care? (With A. Graham, S. Frank and L. Acheson). 12/89. $625. Department of Family Medicine, CWRU: Characteristics of Women Who Deliver With Little or no Prenatal Care. 12/88. $675. PRESENTATIONS International Meetings: Analysis of Health Insurance Mandate Proposals for State Governments: California’s partnership for improving benefits decision making. Panelist. Priorities in Health, Vancouver, Canada, September 2012    

14

Limited Public Health Impacts of California’s Proposed Health Benefit Mandates in 2011. North American Primary Care Research Group 39th Annual Meeting, Banff, Alberta, Canada, November 2011.  New Technology for Breast Cancer Screening: Pragmatic Cost Effectiveness Analysis for a State Safety-net Program. North American Primary Care Research Group 38th Annual Meeting. Seattle, WA, November 2010 Strategies for Surveillance After Treatment for Cervical Intraepithelial Neoplasia (CIN): Costs and Outcomes. North American Primary Care Research Group 37th Annual Meeting. Montreal, Quebec, November 2009. Surveillance After Treatment for CIN: HPV Testing is Not Cost-Effective. Papillomavirus Conference. 25th International, Malmo, Sweden. May 2009. The HPV Vaccine: Information Needs, Barriers, and Disparities. North American Primary Care Research Group. 36th Annual Meeting. November 2008. Recurrent of Cervical Intraepithelial Neoplasia Following Treatment: A Population-bases Cohort Study. North American Primary Care Research Group. 35th Annual Meeting. October 2007. Recruitment Strategies for Minority Participation: Challenges and Costs. North American Primary Care Research Group. 33rd Annual Meeting. October 2005. Tamoxifen for Breast Cancer Risk Reduction: Is it Cost Effective? North American Primary Care Research Group. 31st Annual Meeting. October 2003. Breast Cancer Concern and Sources of Breast Cancer Information. SGIM 26th Annual Meeting. Vancouver, British Columbia, April 30-May 3, 2003. Tamoxifen Prevention of Breast Cancer: Is it Acceptable to Women at Risk? Generalist Physicians as Agents for Change: Education and Research Practice and Policy. SGIM 26th Annual Meeting. Vancouver, British Columbia, April 30-May 3, 2003. Tamoxifen Prevention of Breast Cancer: Is it Acceptable to Women at Risk? North American Primary Care Research Group. 29th Annual Meeting. Halifax, Nova Scotia, October 2001. Mildly Abnormal Pap Smears: What is Cost-Effective Management? North American Primary Care Research Group. 26th Annual Meeting. Montreal, Quebec, November 1998/99. Natural History of Cervical Dysplasia: A Meta-analysis. 5th International Cochrane Colloqium. Amsterdam, the Netherlands, October 1997. Breast Cancer Concern and Sources of Breast Cancer Information: An Interview Study. North American Primary Care Research Group 30th Annual Meeting, Building Research Capacity, New Orleans, Louisiana, November 17-20, 2002. I’m Going to Die of Something Anyway – Women’s Perceptions of Tamoxifen for Breast

15

Cancer Risk Reduction. North American Primary Care Research Group 30th Annual Meeting, Building Research Capacity, New Orleans, Louisiana, November 17-20, 2002. Tamoxifen for Breast Cancer Risk Reduction: Women’s Perspectives. Society for General Internal Medicine 24th Annual Meeting, San Diego, CA, May 2001. Mildly Abnormal Pap Smears: What is Cost-effective Management? Society for General Internal Medicine Annual meeting. San Francisco, CA, April 1998. Detection of High Grade Cervical Dysplasia - North American Primary Care Research Group Annual Meeting. Vancouver, BC. November 1996. Integrating Adherence Measures in Clinical Trials and Practice (with C. Kiefe, P. Rudd, J. Steiner) Society of General Internal Medicine Annual Meeting. Washington, D.C., April 1994. Research in Compliance: Issues in Methodology. Society of General Internal Medicine, Washington, D.C., May 1992. Characteristics of Women Delivering with Little or no Prenatal Care. North American Primary Care Research Group, San Antonio, Texas, April 1989. National Meetings: Academic Careers for Leadership. National Hispanic Medical Association Policy Residents Program, Sacramento CA, April 20, 2012. From Science to Policy: Challenges in Translating Scientific Evidence Into Practice-Changing Clinical Recommendations and Decision Tools (with Bernett S. Kramer and David F. Ransohoff). American Association for Cancer Research Annual Meeting. Chicago, IL, April 2, 2012. Put Prevention Into Practice. Is it Effective? A controlled Evaluation. Thirty-Third STFM Annual Spring Conference. Orlando, Florida, May 3-7, 2000. Improving the Delivery of Preventive Services in a Community Setting. 14th National Conference on Chronic Disease Prevention and Control. Dallas, TX, December 1999. New Technology for Cervical Cancer Screening in an Era of Managed Care. American Society for Cytopathology Annual Meeting. Sacramento, CA, November 1999. Information Mastery. Invited small group facilitator. University of Virginia Annual Conference, Charlottesville, VA, March 1999. Determining Costs of Health Care Services for Cost-effectiveness Analyses: The Case of Cervical Cancer Prevention and Treatment. Poster presented at “Prevention 97” Conference. Atlanta, GA, April 1997. Prevention and Early Diagnosis of Cervical Cancer - Cancer Information Exchange Second Annual Program. Amelia Island, FL, February 1997.

16

Cancer Prevention in Women. New Advances in Internal Medicine. UCDMC Office of Continuing Medical Education. Monterey, CA. August 1996. A Controlled Evaluation of a New Preventive Services Initiative. Society of Teachers of Family Medicine Annual Meeting. San Francisco. May 1996. Management of Patients with Squamous Atypia on Pap Smear: A Decision Analysis. Society of Teachers of Family Medicine Annual Meeting. Atlanta, GA, April 1994. Lack of Prenatal Care Among Inner City Women: A Case-Control Study. American Public Health Association Annual Meeting. San Francisco, CA, October 1993. Lack of Prenatal Care Among Inner City Women: A Case-Control Study. Society of Teachers of Family Medicine Annual Meeting. San Diego, CA, April 1993. Compliance in Trials and Practice: Issues of Quantification and Analysis (with C. Kiefe, P. Rudd, J. Steiner) Society of General Internal Medicine. Arlington, Virginia, April 1993. Analytic Issues in Medications Compliance Research. Seventh Annual Primary Care Research Methods and Statistics Conference. San Antonio, TX, December 1992. Does the system of pap smear nomenclature affect the role of referral for colposcopy? A survey of Family Physicians. North American Primary Care Research Group, Richmond, VA, April 1992. Primary Care Research in Compliance. Sixth Annual Primary Care Research Methods & Statistics Conference, San Antonio, Texas, December 1991. Regional Meetings: The Importance of Comparative Effectiveness Research in New Technology Development. Benjamin Highman Pathology Symposium. Sacramento, CA., May 2010. What Works: Evidence-based clinical preventive services. Implementing Health Reform: An Emphasis on Prevention. California Health Policy Forum. Sacramento, CA., May 2010. Strategies for Surveillance After Treatment for Cervical Intraepithelial Neoplasia (CIN): Costs and Outcomes. University of Massachusetts, Dept of Quantitative Health Sciences. Worcester, MA, August 2009. Update on Women’s Health. Clinical Application of Recent Advances in Pharmacology. UC Davis CME. Napa, CA 2006. Update on Women’s Health. Clinical Application of Recent Advances in Pharmacology. UC Davis CME. Napa, CA 2005. Menopause After WHI: Now What? The Clinical Application of Recent Advances in Pharmacology. UC Davis CME. Napa, CA. April 2004.

17

Screening for Cervical Cancer: What’s New? What’s Useful? 27th Annual Network Education Conference. Flamingo Resort Hotel & Conference Center, Santa Rosa, CA. February 2002. Tamoxifen for Breast Cancer Risk Reduction: Women’s Perspectives. UC Davis Women’s Center for Health. UC Davis Cancer Center Auditorium, Sacramento, CA. April 2000. Domestic Violence (with Sue Barton, PhD). Davis Kaiser Permanente Primary Care. Davis, CA, December 1999. Expressing Risks and Benefits. Healthwise Medical Team. Park City, UT, November 1999. Cancer Screening and Prevention in Women. UC Davis Women’s Health Conference and Wellness Fair. Sacramento, CA. June 1998. Third Annual Cancer Research Symposium. UC Davis Cancer Program. UC Davis Cancer Center, Sacramento, California. September 1997. Third Stage and Post Partum Emergencies, Neonatal Resuscitation Review. Advanced Life Support in Obstetrics Course. Family Practice Liability Project. Sacramento. May 1996. Management of Patients with an Abnormal Pap Smear. The Team Approach to Oncology: The Role of the Primary Care Physician. U.C. Davis CME, UCDMC, Sacramento, CA, April 1996. Evidence Based Medicine: What is it? How do you do it? How do you teach it? U.C. Davis Family Practice Network Conference, Asilomar, California, February 1996. Colposcopy: Who Needs It? (with Jim Nuovo, M.D.). U.C. Davis Family Practice Network Conference, Asilomar, California, February 1996. Management Choices for Patients with Squamous Atypia on a Pap Smear. A Decision Analysis. U.C. Davis Cancer Center First Annual Cancer Research Symposium. Sacramento, CA September 1995. Psychosocial Issues in Women's Health: Asking About Domestic Violence. University of California, Davis, Family Practice Network Conference, Asilomar, CA, February 1994. Update on Nutrition in Pregnancy and Lactation. Family Practice Liability Project Seminar, Sacramento, California, November 1993. Examining Charges for Care of Acute Asthma: A Project to Increase Student Awareness of the Costs of Medical Care, Northeast Regional Society for Teachers of Family Medicine, New York, New York, October 1990. Characteristics of Inner City Women Delivering with Little or no Prenatal Care, Northeast Regional Society for Teachers of Family Medicine, New York, New York, October 1990. Awarded 1st prize for research presentation.

18

Local Meetings: Strategies for Surveillance After Treatment for Cervical Intraepithelial Neoplasia (CIN): Costs and Outcomes. UC San Francisco Department of Obstetrics and Gynecology Grand Rounds. May 2010. Strategies for Surveillance After Treatment for Cervical Intraepithelial Neoplasia (CIN): Costs and Outcomes. UC Davis Department of Family and Community Medicine Grand Rounds. February 2010. Pathology: Costs, outcomes, and comparative effectiveness research. UC Davis Department of Pathology Grand Rounds. May 2009 Strategies for Surveillance After Treatment for Cervical Intraepithelial Neoplasia (CIN): Costs and Outcomes. UC Davis Department of Obstetrics and Gynecology Research Day, March 2009. Management of Abnormal Pap Smears. UC Davis Cancer Clinical Research Seminar, April 2003. Tamoxifen for Breast Cancer Risk Reducing. What Do We Value? Research Seminary, Center for Health Services Research in Primary Care, December 2003. Management of Abnormal Pap Smears. A Research Odyssey. Department of Family and Community Medicine Grand Rounds. April 2002. Domestic Violence. UC Davis Department of Psychiatry Grand Rounds (with Sue Barton, PhD), November 1999. Clinical Epidemiology and Study Design. Department of Epidemiology and Preventive Medicine and Department of Internal Medicine. University of California, Davis, Medical Center, Sacramento, California. September 13-17, 1999. Hormone Replacement Therapy. UCDMG Nurse Practitioner/Physician Assistants, Sacramento, CA, April 1999. Pathways to Peace: Focus on Youth and Domestic Violence. Sierra Health Foundation, Sacramento, California. October 1998. Oral Contraceptives: New Guidelines. Department of Family and Community Medicine Grand Rounds. May 1998. Domestic Violence in Primary Care. Physicians for Social Responsibility. Sutter Center for Psychiatry CME Program, Sacramento, California. March 1995 (with Sue Barton, Ph.D.). Domestic Violence in Primary Care. Sutter Hospital Medical Staff Meeting, February 1995 (with Sue Barton, Ph.D.). Domestic Violence. University of California, Davis, Medical Center, Department of Family Practice, Health Care to Underserved Populations, (FAP 195), Seventh Annual Lecture Series (with Sue Barton, Ph.D.). February 1995.

19

Domestic Violence. Sacramento County Clinics Staff. Adult Services Center, Sacramento, California. January 1995. Management of Common Breastfeeding Problems. Grand Rounds, Dept. of Family Practice, University of California, Davis, Medical Center, February 1995. Domestic Violence. Grand Rounds, Department of Psychiatry, University of California, Davis, Medical Center. November 1994 (with Sue Barton, Ph.D.). Domestic Violence. Grand Rounds, University of California, Davis, Medical Center, Department of Family Practice, June 1994 (with Sue Barton, Ph.D.). Medication Compliance. Grand Rounds, University of California, Davis, Medical Center, Department of Family Practice, September 1992. Should screening sigmoidoscopy be performed routinely in people over 50? Cleveland Kaiser Permanente Department of Family Practice, February 1991. Promoting successful breastfeeding. Cleveland Fairview General Hospital, Department of Family Practice, February 1991. Women who Deliver with Little or no Prenatal Care. Case Western Reserve University, Department of Family Medicine Annual Research Day, Cleveland, Ohio, June 1989. TEACHING – UCDMC & UC DAVIS Chicano Studies 21S: Overview of Latina/o Health Issues, Oaxaca, Mexico Fall 2008 Chicano Studies 145S: Binational Health, Oaxaca, Mexico Fall 2008 Mentored Clinical Research Training Program: Cost Effectiveness Analysis 2004, 2005, 2006, 2007, 2008, 2010 Family Medicine - Resident Blocktime Conferences: Abnormal Pap Smear 2004-2010 (annual) Menopausal Health 2004 Breast problems 2002, 2004, 2005-2009 Osteoporosis 2/00 Domestic Violence 10/99 Recognition and Reporting of Child Abuse (with Sue Barton, Ph.D.) 9/95, 9/96, 11/99 Series on Evidence-based Medicine 32 hours - Fall and Spring Blocktime 1993-94, 94-95, 95-96, 96-97, 99, 2000, 01 Prenatal Nutrition and Breastfeeding promotion 02/93, 01/94, 2/95 Postpartum Care and Contraception 08/95, 8/96, 8/99, 8/00 First Trimester Bleeding 10/98 Diagnosis of Ectopic Pregnancy 12/92 Evaluating Overviews: Does Digoxin Help in Congestive Heart Failure? 12/93 OB/GYN Resident Conferences:

20

Oral Contraceptive Guidelines 5/98 Predoctoral Education Program: Contraception and Sexuality 7/94, 9/94 Prenatal Care Access in Urban Areas 2/93 Domestic Violence 2/95, 2/97 FNP/PA Program Lectures: Breast Problems. UC Davis Nurse Practitioner/ Physician Assistant Training Program. 2000- 2007 Evidence Based Medicine 2/98 Small Group Facilitator/Lecturer, EPI 299,

Introduction to Clinical Research Design and Epidemiology 9/99 Grant Funding 9/00

Medical Student Teaching: University of California, Davis Doctoring 1 - FAP FAP400 Winter/Spring Quarter - Seminar leader FAP440 Preceptor, Lecturer FAP499 Summer Quarter - Research Supervisor FAP199 Lecture on access to prenatal care EDUCATIONAL ACTIVITIES - Other Invited Tutor at Workshop on How to Teach Evidence Based Medicine, McMaster University School of Medicine, 6/93, 6/95, 6/96, 6/97, 6/99. Consultant, Lactation Management Curriculum for Health Professionals, Wellstart International, 3/98 COMMITTEES North American Primary Care Research Group Program Committee 2009-present Public Health Service Advocacy Network for Departments of Family Medicine 1993-present California Department of Health Services Breast Cancer Screening Protocols Workgroup 1995-1999. Sacramento County Committee to Prevent Infant Mortality 1993-96 County of Sacramento, Department of Health and Human Services, Maternal, Child, and Adolescent Health (MCAH) Programs. Black Infant Health (BIH) Grants Review Committee 1994. California Academy of Family Physicians Research Committee 1995-99 University of California, Davis: Chair, Department of Family and Community Medicine Faculty Search Committee 2010-present Department of Public Health Sciences Policy Faculty Committee 2010-present Research Space Advisory Committee, 2004-present

Center for Health Services Research in Primary Care - Executive Committee 1995-present - Faculty Search Committee 1995-1998

Department of Family and Community Medicine Research Committee 2006-present Ad Hoc Promotion Committee 2000-01 Representative at Large, Academic Assembly 1994-96, 2006-08

21

Honors and Awards Committee 1995-97 Department of Family Practice Ad Hoc Personnel Committee 1993

Department of Family Practice Clinic Director Search Committee 1993 School of Medicine, Dean's Advisory Committee for Women Faculty 1995-1997

U.C.D. Medical Center, Sacramento: Research IV Building Committee 2010-present Cancer Center Executive Committee, 1998 – present Center for Women’s Health Executive Committee, 1998-2002

Pharmacy and Therapeutics Committee, 1994-2009 Breastfeeding Task Force, 1994-1998

REVIEWER ACTIVITIES Journal of Family Practice American Family Physician Archives of Family Medicine Annals of Internal Medicine Annals of Epidemiology American Journal of Epidemiology Journal of the National Cancer Institute SPECIAL INTERESTS Fluent in Spanish Providing clinical care to underserved populations, increasing value in healthcare through evidence-based health policy, using health services and epidemiological research methods to analyze problems and improve health care within underserved populations, women’s health, cancer prevention, preventive health services, and cost effectiveness analysis. Revised 10/17/2011